Utah Medical Products, Inc. (UTMD)

NASDAQ: UTMD · Real-Time Price · USD

69.16

-1.94 (-2.73%)

At close: Sep 8, 2026, 4:00 PM EDT

68.60

-2.50 (-3.52%)

After-hours: Sep 8, 2026, 7:57 PM EDT

Utah Medical Products Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 8, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	220	179	208	306	365	365
Market Cap Growth	12.52%	-14.01%	-31.80%	-16.18%	-0.11%	18.97%
Enterprise Value	133	95	120	218	296	301
Last Close Price	69.16	55.43	59.61	80.22	94.49	92.76

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 8, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	21.07	15.89	15.03	18.38	22.14	24.69
Forward PE	-	17.80	17.80	17.80	17.80	17.80
PS Ratio	6.10	4.65	5.10	6.09	6.98	7.44
PB Ratio	1.80	1.50	1.78	2.38	3.19	3.41
P/TBV Ratio	2.04	1.72	2.07	2.79	4.03	4.85
P/FCF Ratio	19.24	12.52	14.28	14.12	17.93	17.68
P/OCF Ratio	18.59	12.20	14.06	13.72	17.25	17.22
PEG Ratio	-	1.19	1.19	1.19	1.19	1.19

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 8, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	3.68	2.47	2.94	4.34	5.65	6.14
EV/EBITDA Ratio	9.25	6.06	6.49	9.43	11.02	11.51
EV/EBIT Ratio	11.10	7.47	7.65	12.98	14.93	15.95
EV/FCF Ratio	11.61	6.65	8.24	10.06	14.53	14.58

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 8, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.00	0.00	0.00	0.00	0.00	0.00
Debt / EBITDA Ratio	0.01	0.02	0.02	0.01	0.01	0.02
Debt / FCF Ratio	0.02	0.02	0.02	0.01	0.02	0.02
Net Debt / Equity Ratio	-0.72	-0.72	-0.70	-0.72	-0.65	-0.56
Net Debt / EBITDA Ratio	-6.08	-5.44	-4.46	-4.01	-2.79	-2.32
Net Debt / FCF Ratio	-7.63	-5.97	-5.66	-4.28	-3.67	-2.93
Asset Turnover	0.29	0.31	0.32	0.39	0.44	0.43
Inventory Turnover	1.76	1.97	1.82	2.19	2.61	2.83
Quick Ratio	44.01	34.36	23.18	20.44	13.52	17.65
Current Ratio	48.62	37.62	25.64	22.56	15.09	19.54
Return on Equity (ROE)	8.76%	9.54%	11.29%	13.72%	14.88%	14.09%
Return on Assets (ROA)	6.10%	6.51%	7.62%	8.09%	10.33%	10.38%
Return on Invested Capital (ROIC)	28.71%	29.78%	36.87%	36.91%	36.65%	29.85%
Return on Capital Employed (ROCE)	9.80%	10.60%	13.20%	12.80%	16.80%	16.90%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 8, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	4.76%	6.30%	6.65%	5.44%	4.52%	4.05%
FCF Yield	5.20%	7.99%	7.00%	7.08%	5.58%	5.66%
Dividend Yield	1.79%	2.21%	2.02%	1.48%	1.23%	0.92%
Payout Ratio	37.78%	35.29%	30.70%	25.74%	19.20%	77.53%
Buyback Yield / Dilution	4.75%	7.51%	3.68%	0.17%	0.46%	0.33%
Total Shareholder Return	6.54%	9.72%	5.70%	1.64%	1.70%	1.25%

SEC Filings: 10-K · 10-Q